In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes

BACKGROUND: Critically ill patients routinely receive antibiotics with activity against anaerobic gut bacteria. However, in other disease states and animal models, gut anaerobes are protective against pneumonia, organ failure and mortality. We therefore designed a translational series of analyses an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanderraj, Rishi, Baker, Jennifer M., Kay, Stephen G., Brown, Christopher A., Hinkle, Kevin J., Fergle, Daniel J., McDonald, Roderick A., Falkowski, Nicole R., Metcalf, Joseph D., Kaye, Keith S., Woods, Robert J., Prescott, Hallie C., Sjoding, Michael W., Dickson, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909213/
https://www.ncbi.nlm.nih.gov/pubmed/36229047
http://dx.doi.org/10.1183/13993003.00910-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909213/
https://www.ncbi.nlm.nih.gov/pubmed/36229047
http://dx.doi.org/10.1183/13993003.00910-2022

Ejemplares similares